6.3.5.7	(1R,2R)-1-(4-methylsulfonylphenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol	-	84314	
6.3.5.7	(1R,2R)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol	-	84313	
6.3.5.7	(1R,2R)-1-phenyl-2-(S-dioxo-L-methioneamido)-1,3-propanediol	-	84315	
6.3.5.7	(1R,2S)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol	-	84318	
6.3.5.7	(1S,2R)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol	-	84317	
6.3.5.7	(1S,2S)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol	-	84316	
6.3.5.7	2'-O-(trinitrophenyl)adenosine 5'-triphosphate	IC50: 2.4 mM	32023	
6.3.5.7	3'-(L-alpha-aspartylamino)-3'-deoxy-N,N-dimethyladenosine	puromycin analogue	72025	
6.3.5.7	3'-deoxy-3'-(L-alpha-glutamylamino)-N,N-dimethyladenosine	puromycin analogue	72026	
6.3.5.7	3'-deoxy-3'-(L-glutaminylamino)-N,N-dimethyladenosine	puromycin analogue	70132	
6.3.5.7	3'-O-(trinitrophenyl)adenosine 5'-triphosphate	IC50: 2.4 mM	32056	
6.3.5.7	3'-[[(2S)-2-amino-4-(methylsulfinyl)butanoyl]amino]-3'-deoxy-N,N-dimethyladenosine	puromycin analogue	70111	
6.3.5.7	3'-[[(2S)-2-amino-4-(methylsulfonyl)butanoyl]amino]-3'-deoxy-N,N-dimethyladenosine	puromycin analogue	70112	
6.3.5.7	3'-[[(2S)-4-carboxy-2-hydroxybutanoyl]amino]-3'-deoxy-N,N-dimethyladenosine	puromycin analogue	70113	
6.3.5.7	3'-[[2-amino-4-(methylphosphinato)butanoyl]amino]-3'-deoxy-N,N-dimethyladenosine	puromycin analogue	70114	
6.3.5.7	6-diazo-5-oxonorleucine	blocking of glutamine-dependent reaction, no inhibition of ammonia-dependent reaction	20066	
6.3.5.7	adenosine 5'-[beta,gamma-methylene]triphosphate	IC50: 2.3 mM	29702	
6.3.5.7	ADP	IC50: 0.026 mM	13	
6.3.5.7	ATP-gammaS	IC50: 0.19 mM	11164	
6.3.5.7	chloramphenicol	-	955	
6.3.5.7	gamma-Glu boronic acid	IC50: 0.0016 mM	50745	
6.3.5.7	L-methionine-S-sulfoximine	at 1 mM, 3 mM or 5 mM, 20% inhibition	4583	
6.3.5.7	additional information	no inhibition by 6-diazo-5-oxonorleucine	2	
6.3.5.7	puromycin	aminonucleoside antibiotic produced by Streptomyces alboniger, very weak inhibitor of AdT	657